Abstract:Streptococcus suis serotype 2 (S. suis 2) causes sepsis and meningitis in piglets and humans, and results in one of the most serious bacterial diseases affecting the production of commercial pigs around the world. Due to the failure of the current inactivated vaccine to protect against the disease, development of a new attenuated live vaccine against S. suis 2 by deleting essential virulence factors is urgently needed. We have previously reported the construction and characterization of an SsPep single gene deletion mutant strain Delta SsPep based on S. suis 2. Our previous results have shown that SsPep plays a critical role in the pathogenesis of S. suis 2. In this study, a precisely defined double-deletion mutant Delta SsPep/Delta SsPspC of S. suis 2 without antibiotic-resistance markers was constructed based on Delta SsPep, and the levels of virulence of the wild-type (WT) and Delta SsPep/Delta SsPspC were compared in a mouse experimental infection model. We demonstrated that the double mutant Delta SsPep/Delta SsPspC was less virulent than the WT,and could induce a noticeable antibody response. Analysis of IgG subclasses (IgG1 and IgG2a) indicated that both Th1 and Th2 responses were induced by Delta SsPep/Delta SsPspC, although the IgG2a (Th1) response predominated over the IgG1 (Th2) response. Moreover, Delta SsPep/Delta SsPspC could confer 90% protective efficacy against challenge with a lethal dose of fully virulent S. suis 2. Taken together, these data demonstrate that Delta SsPep/Delta SsPspC can be used as an effective live vaccine and provide a novel strategy against infection of S. suis 2. (C) 2014 Elsevier GmbH. All rights reserved.

Establishment of Pathologic Model for Studying Streptococcus Suis Serotype 2 in Kunming Mice

Establishment of Infection Model for Streptococcus Suis Serotype 2 in Mini-Pig

Establishment of Experimental Animal Model with Eperythrozoon Suis

Experimental Infection and Pathology of Rabbits with Streptococcus Suis Serotype 2

Model of Piglet Infected by Streptococcus suis Type 2 and Immune Protective Trial of Vaccine against Swine Streptococcosis

Genetic and Virulence Characterization of Streptococcus Suis Type 2 Isolates from Swine in the Provinces of Zhejiang and Henan, China

Experimental Animal Models of BALB / C Mice Infected with Streptococcus Suis

Pathogenesis Comparison of the Pathogenicity of Streptococcus Suis Serotype 2 Isolated from Sichuan and Jiangsu

Identification and Characterization of Streptococcus Suis Serotype 2 Isolated from Diseased Pigs in Ziyang Area of Sichuan Province

Study on Immunological Examination in Blood with Two Streptococcus Suis Serotype 2 Strains Infection in Miniature Swine Model

Isolation and Identification of the Streptococcus Suis Serotypes Ⅱ Shandong Virulent Strain

Isolation and Identification of Swine Streptococus Suis Serotype 2

Location and Dynamic Distribution of Serotype 2 Streptococcus Suis in Tissues and Organs of Infected SPF Pigs

Pathologic Analysis of the Brain from Streptococcus Suis Type 2 Experimentally Infected Pigs

Characterization of Streptococcus Suis Serotype 2 Isolates from China.

Construction, Characterization And Evaluation Of The Protective Efficacy Of The Streptococcus Suis Double Mutant Strain Delta Sspep/Delta Sspspc As A Live Vaccine Candidate In Mice

Virulence Genotyping and Population Analysis of Streptococcus Suis Serotype 2 Isolates from China.

Pathogenic Characteristics of Streptococcus Suis Type 2 and Type 9 Isolated from Guangdong Province

Streptococcus Isolated from Pig with High Fever Syndrome and Its Pathogenesis in Mice

Study on the Amoxillin-Tylosin Tartrate Compound Against Streptococcos Suis in Mice

Guinea-Pig Model of Streptococcus suis Type 2 Induced Meningitis and Septicaemia